Regulation of CXCL8/IL-8 expression by zonula occludens-1 in human breast cancer cells

Molecular Cancer Research

Volumn 10, Issue 1, 2012, Pages 121-132

  Brysse, Anne ^a   Mestdagt, Mélanie ^a   Polette, Myriam ^b   Luczka, Emilie ^b   Hunziker, Walter ^c   Noël, Agnès ^a   Birembaut, Philippe ^b   Foidart, Jean Michel ^a   Gilles, Christine ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b HÔPITAL MAISON BLANCHE   (France)

^c INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; INTERLEUKIN 8; MESSENGER RNA; PROTEIN ZO1; SMALL INTERFERING RNA;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CONTROLLED STUDY; DNA MICROARRAY; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TARGETING; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CARCINOMA; CELLS, CULTURED; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-8; MEMBRANE PROTEINS; MICROARRAY ANALYSIS; NEOPLASM INVASIVENESS; PHOSPHOPROTEINS; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84855995952     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-11-0180     Document Type: Article

References (56)

1. Conacci-Sorrell M, Zhurinsky J, Ben Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 2002;109:987-91. (Pubitemid 34408571)
2. Van Roy F, Berx G. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci 2008;65:3756-88.
3. Gonzalez-Mariscal L, Lechuga S, Garay E. Role of tight junctions in cell proliferation and cancer. Prog Histochem Cytochem 2007;42:1-57. (Pubitemid 46722725)
4. Martin TA, Jiang WG. Loss of tight junction barrier function and its role in cancer metastasis. Biochim Biophys Acta 2009;1788:872-91.
5. Balda MS, Matter K. Tight junctions at a glance. J Cell Sci 2008;121:3677-82.
6. Bauer H, Zweimueller-Mayer J, Steinbacher P, Lametschwandtner A, Bauer HC. The dual role of zonula occludens (ZO) proteins. J Biomed Biotechnol 2010;2010:402593.
7. Furuse M. Molecular basis of the core structure of tight junctions. Cold Spring Harb Perspect Biol 2010;2:a002907.
8. Martin TA, Watkins G, Mansel RE, Jiang WG. Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer. Eur J Cancer 2004;40:2717-25. (Pubitemid 39574723)
9. Kleeff J, Shi X, Bode HP, Hoover K, Shrikhande S, Bryant PJ, et al. Altered expression and localization of the tight junction protein ZO-1 in primary and metastatic pancreatic cancer. Pancreas 2001;23:259-65. (Pubitemid 32910974)
10. Resnick MB, Gavilanez M, Newton E, Konkin T, Bhattacharya B, Britt DE, et al. Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation. Hum Pathol 2005;36:886-92. (Pubitemid 41187907)
11. Smalley KS, Brafford P, Haass NK, Brandner JM, Brown E, Herlyn M. Up-regulated expression of zonula occludens protein-1 in human melanoma associates with N-cadherin and contributes to invasion and adhesion. Am J Pathol 2005;166:1541-54. (Pubitemid 40586522)
12. Gottardi CJ, Arpin M, Fanning AS, Louvard D. The junction-associated protein, zonula occludens-1, localizes to the nucleus before the maturation and during the remodeling of cell-cell contacts. Proc Natl Acad Sci U S A 1996;93:10779-84. (Pubitemid 26333066)
13. Benezra M, Greenberg RS, Masur SK. Localization of ZO-1 in the nucleolus of corneal fibroblasts. Invest Ophthalmol Vis Sci 2007;48:2043-9. (Pubitemid 351261273)
14. Gonzalez-Mariscal L, Islas S, Contreras RG, Garcia-Villegas MR, Betanzos A, Vega J, et al. Molecular characterization of the tight junction protein ZO-1 in MDCK cells. Exp Cell Res 1999;248:97-109. (Pubitemid 29393933)
15. Polette M, Mestdagt M, Bindels S, Nawrocki-Raby B, Hunziker W, Foidart JM, et al. Beta-catenin and ZO-1: shuttle molecules involved in tumor invasion-associated epithelial-mesenchymal transition processes. Cells Tissues Organs 2007;185:61-5. (Pubitemid 46956844)
16. Balda MS, Matter K. Epithelial cell adhesion and the regulation of gene expression. Trends Cell Biol 2003;13:310-8. (Pubitemid 36638798)
17. Reichert M, Muller T, Hunziker W. The PDZ domains of zonula occludens-1 induce an epithelial to mesenchymal transition of Madin-Darby canine kidney I cells. Evidence for a role of beta-catenin/Tcf/Lef signaling. J Biol Chem 2000;275:9492-500. (Pubitemid 30185178)
18. Polette M, Gilles C, Nawrocki-Raby B, Lohi J, Hunziker W, Foidart JM, et al. Membrane-type 1 matrix metalloproteinase expression is regulated by zonula occludens-1 in human breast cancer cells. Cancer Res 2005;65:7691-8. (Pubitemid 41297243)
19. Lazennec G, Richmond A. Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med 2010;16:133-44.
20. Mantovani A, Savino B, Locati M, Zammataro L, Allavena P, Bonecchi R. The chemokine system in cancer biology and therapy. Cytokine Growth Factor Rev 2010;21:27-39.
21. Waugh DJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res 2008;14:6735-41.
22. Mehrad B, Keane MP, Strieter RM. Chemokines as mediators of angiogenesis. Thromb Haemost 2007;97:755-62. (Pubitemid 46804315)
23. Singh S, Sadanandam A, Singh RK. Chemokines in tumor angiogenesis and metastasis. Cancer Metastasis Rev 2007;26:453-67. (Pubitemid 350115099)
24. Salcedo R, Resau JH, Halverson D, Hudson EA, Dambach M, Powell D, et al. Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells. FASEB J 2000;14:2055-64.
25. Li A, Varney ML, Valasek J, Godfrey M, Dave BJ, Singh RK. Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis. Angiogenesis 2005;8:63-71. (Pubitemid 41223840)
26. Gabellini C, Trisciuoglio D, Desideri M, Candiloro A, Ragazzoni Y, Orlandi A, et al. Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression. Eur J Cancer 2009;45:2618-27.
27. De Larco JE, Wuertz BR, Rosner KA, Erickson SA, Gamache DE, Manivel JC, et al. A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells. Am J Pathol 2001;158:639-46. (Pubitemid 32158624)
28. Snoussi K, Mahfoudh W, Bouaouina N, Fekih M, Khairi H, Helal AN, et al. Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness. BMC Cancer 2010;10:283.
29. Uehara H, Troncoso P, Johnston D, Bucana CD, Dinney C, Dong Z, et al. Expression of interleukin-8 gene in radical prostatectomy specimens is associated with advanced pathologic stage. Prostate 2005;64:40-9. (Pubitemid 40734737)
30. Green AR, Green VL, White MC, Speirs V. Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: identification of interleukin-8 as a potential regulatory factor in breast tumours. Int J Cancer 1997;72:937-41. (Pubitemid 27433554)
31. Chavey C, Bibeau F, Gourgou-Bourgade S, Burlinchon S, Boissiere F, Laune D, et al. Oestrogen receptor negative breast cancers exhibit high cytokine content. Breast Cancer Res 2007;9:R15.
32. Eck M, Schmausser B, Scheller K, Brandlein S, Muller-Hermelink HK. Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma. Clin Exp Immunol 2003;134:508-15. (Pubitemid 37542093)
33. Mestdagt M, Polette M, Buttice G, Noel A, Ueda A, Foidart JM, et al. Transactivation of MCP-1/CCL2 by beta-catenin/TCF-4 in human breast cancer cells. Int J Cancer 2006;118:35-42. (Pubitemid 41681578)
34. Levy L, Neuveut C, Renard CA, Charneau P, Branchereau S, Gauthier F, et al. Transcriptional activation of interleukin-8 by beta-catenin-Tcf4. J Biol Chem 2002;277:42386-93.
35. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997;275:1784-7. (Pubitemid 27136714)
36. Lee WH, Kim SH, Jeong EM, Choi YH, Kim DI, Lee BB, et al. A novel chemokine, Leukotactin-1, induces chemotaxis, pro-atherogenic cytokines, and tissue factor expression in atherosclerosis. Atherosclerosis 2002;161:255-60. (Pubitemid 34219177)
37. Sommers CL, Byers SW, Thompson EW, Torri JA, Gelmann EP. Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res Treat 1994;31:325-35. (Pubitemid 24323473)
38. Brown KA, Aakre ME, Gorska AE, Price JO, Eltom SE, Pietenpol JA, et al. Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro. Breast Cancer Res 2004;6:R215-31.
39. Freund A, Jolivel V, Durand S, Kersual N, Chalbos D, Chavey C, et al. Mechanisms underlying differential expression of interleukin-8 in breast cancer cells. Oncogene 2004;23:6105-14. (Pubitemid 39178863)
40. Dall'Oglio MF, Coelho RF, Leite KR, Sousa-Canavez JM, Oliveira PS, Srougi M. Gene expression profile of renal cell carcinoma clear cell type. Int Braz J Urol 2010;36:410-8.
41. Singh RK, Gutman M, Radinsky R, Bucana CD, Fidler IJ. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res 1994;54:3242-7. (Pubitemid 24208936)
42. Bar-Eli M. Role of interleukin-8 in tumor growth and metastasis of human melanoma. Pathobiology 1999;67:12-8. (Pubitemid 29037606)
43. Bieche I, Chavey C, Andrieu C, Busson M, Vacher S, Le CL, et al. CXC chemokines located in the 4q21 region are up-regulated in breast cancer. Endocr Relat Cancer 2007;14:1039-52. (Pubitemid 351252435)
44. Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD, et al. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Clin Cancer Res 2000;6:2104-19. (Pubitemid 30305111)
45. Ning Y, Manegold PC, Hong YK, Zhang W, Pohl A, Lurje G, et al. Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models. Int J Cancer 2011;128:2038-49.
46. Chikazawa M, Inoue K, Fukata S, Karashima T, Shuin T. Expression of angiogenesis-related genes regulates different steps in the process of tumor growth and metastasis in human urothelial cell carcinoma of the urinary bladder. Pathobiology 2008;75:335-45.
47. Lurje G, Husain H, Power DG, Yang D, Groshen S, Pohl A, et al. Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinoma. Ann Oncol 2010;21:78-86.
48. Ugurel S, Rappl G, Tilgen W, Reinhold U. Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival. J Clin Oncol 2001;19:577-83. (Pubitemid 32112873)
49. Xie LQ, Bian LJ, Li Z, Li Y, Liang YJ. Co-elevated expression of hepatocyte growth factor and Interleukin-8 contributes to poor prognosis of patients with primary nasopharyngeal carcinoma. Oncol Rep 2010;23:141-50.
50. Takai E, Tan X, Tamori Y, Hirota M, Egami H, Ogawa M. Correlation of translocation of tight junction protein Zonula occludens-1 and activation of epidermal growth factor receptor in the regulation of invasion of pancreatic cancer cells. Int J Oncol 2005;27:645-51.
51. Balda MS, Matter K. The tight junction protein ZO-1 and an interacting transcription factor regulate ErbB-2 expression. EMBO J 2000;19:2024-33. (Pubitemid 30237578)
52. Aho S, Lupo J, Coly PA, Sabine A, Castellazzi M, Morand P, et al. Characterization of the ubinuclein protein as a new member of the nuclear and adhesion complex components (NACos). Biol Cell 2009;101:319-34.
53. Gruffat H, Lupo J, Morand P, Boyer V, Manet E. The nuclear and adherent junction complex component protein ubinuclein negatively regulates the productive cycle of Epstein-Barr virus in epithelial cells. J Virol 2011;85:784-94.
54. Masckauchan TN, Shawber CJ, Funahashi Y, Li CM, Kitajewski J. Wnt/ beta-catenin signaling induces proliferation, survival and interleukin-8 in human endothelial cells. Angiogenesis 2005;8:43-51. (Pubitemid 41223838)
55. Mukaida N, Okamoto S, Ishikawa Y, Matsushima K. Molecular mechanismof interleukin-8 gene expression. J Leukoc Biol 1994;56:554-8. (Pubitemid 24348811)
56. Iguchi A, Kitajima I, Yamakuchi M, Ueno S, Aikou T, Kubo T, et al. PEA3 and AP-1 are required for constitutive IL-8 gene expression in hepatoma cells. Biochem Biophys Res Commun 2000;279:166-71.